pfizer glp 1 agonist 2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Drugs Focus on Glucagon-like Peptide-1 Target:

Learn more about its role in diabetes management.

Explore natural alternatives to GLP-1 drugs like Ozempic and Mounjaro

Glucagon-like peptide-1 agonists (GLP-1s) have been in the spotlight as demand has grown to support type 2 diabetes and weight loss

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Learn why some patients cannot tolerate these medications and when endoscopic sleeve may be considered.

Novo Nordisk research has explored how GLP-1 medications like Wegovy can quieten food noise, resulting in a healthier lifestyle, according to respondents.